Urinary Tract Infection

The ability of antibiotic stewardship programs to control and reduce the unnecessary use of antibiotics could be improved by addressing several research gaps, according to a Society for Healthcare Epidemiology of America white paper published in Infection Control & Hospital Epidemiology.

An FDA committee voted to recommend the approval of cefiderocol for the treatment complicated UTIs, or cUTIs, in patients with few or no alternative treatment options.

CHICAGO — Preoperative opioid exposure was linked with significant perioperative consequences and postoperative complications in patients who underwent foot and ankle surgery, according to a presenter at the American Orthopaedic Foot & Ankle Society Annual Meeting.

News that the CDC launched an infection control training program and a study that found fluoroquinolone use decreased after the FDA’s 2016 black box warning were among the top stories in infectious disease last week.

Among the top stories in infectious disease last week were findings that showed doxycycline prophylaxis may be a promising strategy to prevent bacterial sexually transmitted infections, and a study that indicated UTIs are increasingly diagnosed in outpatient settings through virtual care.

The prevalence of health care-associated infections in Canadian hospitals declined 30% between 2009 and 2017, falling to 7.9%, researchers reported.

Researchers found that more than 70% of UTIs at University of North Carolina hospitals were non-device associated, according to recently published study findings.

The rate of UTIs diagnosed in the outpatient setting increased between 2008 and 2017, especially among older adults and in patients receiving virtual care, researchers reported in Clinical Infectious Diseases.

Research published in Pediatrics suggests that infants aged 60 days and younger with bacteremic UTI could receive shorter courses of parenteral antibiotics without the risk for readmission or recurrent infection.

A review of the initial use of seven new antimicrobial agents at six community hospitals in western Pennsylvania revealed that uptake occurred within 1 to 2 years of FDA approval, and researchers observed that ceftolozane-tazobactam and ceftazidime-avibactam were more frequently chosen for off-label use.